Guidelines for Surveillance Colonoscopy. Routine baseline colonoscopy with good to excellent prep; no precancerous polyps, no significant family history or advanced polyps: Interval to next exam is 10 years. Small rectal hyperplastic polyps: Colonoscopy or other screening options at intervals recommended for average-risk individuals.
Two Sets of Procedure Codes Used for Screening Colonoscopy: CPT® code 45378 Colonoscopy, flexible, proximal to splenic flexure; diagnostic, with or without collection of specimen (s) by brushing or washing, with or without colon decompression (separate procedure) and Healthcare Common Procedural Coding System (HCPCS) codes G0105 and G0121
Screening is crucial for cancer detection because most colorectal cancers don’t cause symptoms in the early stages. Many times, doctors first spot colon cancer during a routine screening colonoscopy. During a colonoscopy: Your gastroenterologist uses a flexible tube with a camera at the end to look at the insides of your colon.
To report screening colonoscopy on a patient not considered high risk for colorectal cancer, use HCPCS code G0121 and diagnosis code Z12. 11 (encounter for screening for malignant neoplasm of the colon).
If the patient presents for a screening colonoscopy and a polyp or any other lesion/diagnosis is found, the primary diagnosis is still going to be Z12. 11, Encounter for screening for malignant neoplasm of colon. The coder should also report the polyp or findings as additional diagnosis codes.
The colonoscopy or sigmoidoscopy is still classified as a preventive service eligible for coverage at the no-member-cost-share benefit level. a. Submit the claim with Z12. 11 (Encounter for screening for malignant neoplasm of colon) as the first-listed diagnosis code; this is the reason for the service or encounter.
Z12. 11 Encounter for screening for malignant neoplasm of colon - ICD-10-CM Diagnosis Codes.
There are 2 different sets of screening colonoscopy codes: There are payors that accept the Z12. 11 (encounter for screening for malignant neoplasm of colon) in the first coding position, while other payors either require this diagnosis in a subsequent position behind family history codes or prefer to see the Z12.
“Example: In the course of performing a fiber optic colonoscopy (CPT code 45378), a physician performs a biopsy on a lesion (code 45380) and removes a polyp (code 45385) from a different part of the colon. The physician bills for codes 45380 and 45385.
Medicare and most insurance carriers will pay for screening colonoscopies once every 10 years. Surveillance colonoscopies are performed on patients who have a prior personal history of colon polyps or colon cancer. Medicare will pay for these exams once every 24 months.
A family of CPT codes applies to colonoscopy. For example, code 45378 applies to a colonoscopy in which no polyp is detected, while codes 45380-45385 apply to colonoscopy that involves an intervention (e.g., 45385 is the code for colonoscopy with polypectomy.)
A diagnostic colonoscopy, while basically the same procedure, is used in different situations than a screening colonoscopy. Diagnostic colonoscopies are used when a patient exhibits specific symptoms that may indicate colon cancer or other issues.
Z12. 12 Encounter for screening for malignant neoplasm of rectum - ICD-10-CM Diagnosis Codes.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
ICD-10 code Z12. 39 for Encounter for other screening for malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
The term "malignant neoplasm" means that a tumor is cancerous. A doctor may suspect this diagnosis based on observation — such as during a colonoscopy — but usually a biopsy of the lesion or mass is needed to tell for sure whether it is malignant or benign (not cancerous).
Official Long Descriptor. Encounter for screening for malignant neoplasms. Screening is the testing for disease or disease precursors in asymptomatic individuals so that early detection and treatment can be provided for those who test positive for the disease.
Colonoscopy. In this test, the rectum and entire colon are examined using a colonoscope, a flexible lighted tube with a lens for viewing and a tool for removing tissue.
31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
To report screening colonoscopy on a patient not considered high risk for colorectal cancer, use HCPCS code G0121 and diagnosis code Z12.11 ( encounter for screening for malignant neoplasm of the colon ).
As such, “screening” describes a colonoscopy that is routinely performed on an asymptomatic person for the purpose of testing for the presence of colorectal cancer or colorectal polyps. Whether a polyp or cancer is ultimately found does not ...
Typically, procedure codes with 0, 10 or 90-day global periods include pre-work, intraoperative work, and post-operative work in the Relative Value Units (RVUs) assigned . As a result, CMS’ policy does not allow for payment of an Evaluation and Management (E/M) service prior to a screening colonoscopy. In 2005, the Medicare carrier in Rhode Island explained the policy this way:
Diagnosis Code Ordering is Important for a Screening Procedure turned Diagnostic. When the intent of a visit is screening, and findings result in a diagnostic or therapeutic service, the ordering of the diagnosis codes can affect how payers process the claim.
Screening colonoscopy is a service with first dollar coverage. A screening test with an A or B rating from the US Preventive Services Task Force, should have no patient due amount, since the Affordable Care Act (ACA) was passed.
The patient has never had a screening colonoscopy. The patient has no history of polyps and none of the patient’s siblings, parents or children has a history of polyps or colon cancer. The patient is eligible for a screening colonoscopy. Reportable procedure and diagnoses include:
However, diagnostic colonoscopy is a test performed as a result of an abnormal finding, sign or symptom. Medicare does not waive the co-pay and deductible when the intent of the visit is to perform a diagnostic colonoscopy.
Definition of Terms Colonoscopy: A colonoscopy is a procedure that permits the direct examination of the mucosa of the entire colon by using a flexible lighted tube. The procedure is done with sedation in a hospital outpatient department, in a clinic , or an office facility. During the colonoscopy a doctor can biopsy and remove pre – cancerous ...
During the colonoscopy a doctor can biopsy and remove pre – cancerous polyps and some early stage cancers and also diagnose other conditions or diseases. General definitions of procedure indications from various specialty societies , including the ACA: * A screening colonoscopy is done to look for disease, such as cancer, ...
It can also be doneas a diagnostic procedure when symptoms or lab tests suggest there might be a problem in the rectum or colon.In some cases, minor procedures may be done during a colonoscopy,such as taking a biopsy or destroying an area of unhealthy tissue (a lesion).
This guideline applies only to people of average risk. Colonoscopy is only one of the screening tests that can be used. This benefit coverage guideline provides general information about how the health plan decides whether a colonoscopy is covered under the preventive or diagnostic (medical) benefits.
Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result
For multi-target stool DNA (sDNA) test, use Z12.11 Encounter for screening for malignant neoplasm of colon and Z12.12 Encounter for screening for malignant neoplasm of rectum.
For colorectal cancer screening using multitarget sDNA test, coverage applies to all Medicare patients who fall are:
For patients not meeting criteria for high risk, frequency limitations are:
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Abstract: This article represents local instructions for CMS National Coverage Policy (CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Section 210.3).
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
Preventive Services Task Force (USPSTF):#N#A screening colonoscopy is performed once every 10 years for asymptomatic patients aged 50-75 with no history of colon cancer, polyps, and/or gastrointestinal disease.#N#A surveillance colonoscopy can be performed at varying ages and intervals based on the patient’s personal history of colon cancer, polyps, and/or gastrointestinal disease. Patients with a history of colon polyp (s) are not recommended for a screening colonoscopy, but for a surveillance colonoscopy. Per the USPSTF, “When the screening test results in the diagnosis of clinically significant colorectal adenomas or cancer, the patient will be followed by a surveillance regimen and recommendations for screening are no longer applicable.”#N#The USPSTF does not recommend a particular surveillance regime for patients who have a personal history of polyps and/or cancer; however, surveillance colonoscopies generally are performed in shortened intervals of two to five years. Medical societies, such as the American Society of Colon and Rectal Surgeons and the American Society of Gastrointestinal Endoscopy, regularly publish recommendations for colonoscopy surveillance.#N#The type of colonoscopy will fall into one of three categories, depending on why the patient is undergoing the procedure.#N#Diagnostic/Therapeutic colonoscopy (CPT® 45378 Colonoscopy, flexible, proximal to splenic flexure; diagnostic, with or without collection of specimen (s) by brushing or washing, with or without colon decompression (separate procedure))#N#Patient has a gastrointestinal sign, symptom (s), and/or diagnosis.#N#Preventive colonoscopy screening (CPT® 45378, G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk)#N#Patient is 50 years of age or older#N#Patient does not have any gastrointestinal sign, symptom (s), and/or relevant diagnosis#N#Patient does not have any personal history of colon cancer, polyps, and/or gastrointestinal disease#N#Patient may have a family history of gastrointestinal sign, symptom (s), and/or relevant diagnosis#N#Exception: Medicare patients with a family history (first degree relative with colorectal and/or adenomatous cancer) may qualify as “high risk.” Colonoscopy for these patients would not be a “surveillance,” but a screening, reported with HCPCS Level II code G0105 Colorectal cancer screening; colonoscopy on individual at high risk.#N#Surveillance colonoscopy (CPT® 45378, G0105)#N#Patient does not have any gastrointestinal sign, symptom (s), and/or relevant diagnosis.#N#Patient has a personal history of colon cancer, polyps, and/or gastrointestinal disease.
Medical societies, such as the American Society of Colon and Rectal Surgeons and the American Society of Gastrointestinal Endoscopy, regularly publish recommendations for colonoscopy surveillance. The type of colonoscopy will fall into one of three categories, depending on why the patient is undergoing the procedure.
To avoid angry, confused patients, educate them about the types of colonoscopy (preventative, surveillance, or diagnostic) and insurance benefits associated with each procedure . Accomplish this by providing the patient with the correct tools.
According to ICD-9-CM Official Guidelines for Coding and Reporting, section 18.d.4:#N#There are two types of history V codes, personal and family . Personal history codes explain a patient’s past medical condition that no longer exists and is not receiving any treatment, but that has the potential for recurrence, and therefore may require continued monitoring. Personal history codes may be used in conjunction with follow-up codes and family history codes may be used in conjunction with screening codes to explain the need for a test or procedure.#N#Common personal history codes used with colonoscopy are V12.72 and V10.0x Personal history of malignant neoplasm of the gastrointestinal tract. The family history codes include V16.0 Family history of malignant neoplasm of the gastrointestinal tract; V18.51 Family history of colonic polyps; and V18.59 Family history of other digestive disorders. Lastly, V76.51 describes screening of the colon.#N#Per the ICD-9-CM official guidelines, you would be able to report V76.51 (screening) primary to V16.0 (family history of colon polyps). In contrast, you would not use V76.51 (screening) with V12.72 (personal history of colon polyps) because family history codes, not personal history codes, should be paired with screening codes. Personal history would be paired with a follow-up code.#N#Just because you get paid doesn’t mean the coding is correct: Most carriers will pay V76.51 with V12.72 because their edits are flawed and allow it. The patient’s claim will process under a patient’s preventative benefits with no out-of-pocket; however, an audit of the record with the carrier guidance will reveal that the claim incorrectly paid under preventative services when, in fact, the procedure should have paid as surveillance. The best strategy is to contact your payer to be sure you are coding correctly based on that payer’s “screening vs. surveillance” guidelines.
Practices performing colonoscopies for colon and rectal cancer screenings have seen a corresponding rise in requests for “screening” colonoscopy. As a result, there is an increase in incorrectly coded colonoscopies. Practices may not understand that a majority of patients are actually not screening colonoscopies, ...
Colonoscopy for these patients would not be a “ surveillance,” but a screening, reported with HCPCS Level II code G0105 Colorectal cancer screening; colonoscopy on individual at high risk. Patient does not have any gastrointestinal sign, symptom (s), and/or relevant diagnosis.
Under the ACA, payers must offer first-dollar coverage for screening colonoscopy but are not obliged to do so for a surveillance or diagnostic colonoscopy. The patient’s history and findings determine the reason for and type of colonoscopy, driving the benefit determination.
Colonoscopy is a widely used endoscopic technique used to screen individuals for colorectal cancer. It is very sensitive in detecting colorectal cancers. Colonoscopy is an endoscopic procedure in which a thin tube with a camera at the tip is introduced through the anus till the start of the colon.
After the patient's bowel has been prepped, the physician inserts the colonoscope-a long, thin, flexible lighted tube-through the anus and advances the scope through the colon past the splenic flexure. The lumen of the colon and rectum is visualized. Most polyps and some cancers can be removed during this procedure.